Medicare Part B Premiums and Deductibles Are Rising Again. Here's What to Actually Budget.

The conventional wisdom for Medicare beneficiaries is that premiums and deductibles see modest, predictable increases each year. However, the latest projections from the 2026 Medicare Trustees Report paint a starker picture for 2027, directly impacting those on fixed incomes. The standard monthly Part B premium is expected to climb 3.5% to $209.50, an increase of $6.60 from 2026 [c4, c5, c6]. This might sound like a small number, but for many, it's a significant chunk of their budget. Furthermore, the standard Part D prescription drug deductible is slated to jump to $700, a substantial $85 increase from the 2026 figure of $615

"The latest Social Security and Medicare Trustees Report (page 207) estimates that Part B premiums will climb 3.5% in 2027, reaching $209.50 per month, up $6.60 from 2026." and "The standard Part D deductible will increase to $700 in 2027, up from $615 in 2026."

. The Boards of Trustees released this report on June 9, 2026, detailing these financial shifts

"The Boards of Trustees issued their most recent report on June 9, 2026."

. While the Centers for Medicare & Medicaid Services (CMS) finalized a 2.48% average increase in 2027 Medicare Advantage payments, which some analysts see as positive for insurers like UnitedHealth and Humana [c1, c2], this doesn't directly translate to lower out-of-pocket costs for beneficiaries. The base beneficiary premium for Part D in 2027 is set at $41.33, a figure that doesn't account for the deductible rise

"For 2027, the base beneficiary premium will be $41.33."

.

The headline figure of $209.50 for the Part B premium in 2027 might be the "standard," but it's crucial to understand what that entails. This increase, a $6.60 jump from 2026, is based on the 2026 Medicare Trustees Report [c4, c5, c6]. For those receiving Social Security, these increases are typically deducted directly from their monthly checks. While the Social Security Administration announced a 3.2% cost-of-living adjustment (COLA) for 2024, these Medicare increases can quickly outpace it, effectively negating any gains. This means that while your benefit check might appear larger, your actual spendable income could shrink. The Boards of Trustees' report, issued June 9, 2026, provides the basis for these projections

"The Boards of Trustees issued their most recent report on June 9, 2026."

, and it's a document that directly influences your household budget more than many realize.

The jump in the Part D deductible to $700 for 2027 is a particularly sharp blow

"The latest Social Security and Medicare Trustees Report (page 207) estimates that Part B premiums will climb 3.5% in 2027, reaching $209.50 per month, up $6.60 from 2026." and "The standard Part D deductible will increase to $700 in 2027, up from $615 in 2026."

. This represents an $85 increase from the 2026 deductible. For seniors managing chronic conditions and relying on multiple prescription medications, this higher upfront cost can be a significant barrier. It means more money out-of-pocket before insurance even begins to cover a portion of drug costs. While the "base beneficiary premium" for Part D is projected at $41.33 for 2027

"For 2027, the base beneficiary premium will be $41.33."

, this figure is separate from the deductible. The cumulative effect of higher premiums and a higher deductible means beneficiaries are paying more for their coverage and facing larger immediate expenses when filling prescriptions. This is the kind of "utilization management" the industry loves to talk about, which, for the consumer, often just means paying more.

While beneficiaries brace for higher costs, the landscape for Medicare Advantage (MA) plans and their parent companies can look quite different. CMS finalized a 2.48% average increase in 2027 Medicare Advantage payments

$UNH , $HUM , and $OSCR shares are trading higher after CMS finalized a 2.48% average increase in 2027 Medicare Advantage payments, above expectation. https://t.co/0Z0Mf28Abh

— Wall St Engine link

. Some financial analysts noted this was "above expectation" and saw shares of companies like UnitedHealth Group ($UNH) and Humana ($HUM) trading higher [c1, c2]. This suggests that while traditional Medicare costs are rising for beneficiaries, the financial incentives for MA plans are potentially improving. This creates a bifurcated system where the government-backed programs face cost pressures that are passed to consumers, while private MA plans may see their profitability bolstered by federal adjustments. It’s a complex interplay, but the end result for many seniors is simply higher out-of-pocket expenses.